Patents Assigned to INCURON, INC.
  • Combination therapies with curaxins
    Patent number: 10434086
    Abstract: Provided herein are methods and compositions that relate to, inter alia, CBL0137, a carbazole compound 1,1?-[9-[2-[(1-methylethyl)amino]ethyl]-9H-carbazole-3,6-diyl]bis-ethanone, useful for the treatment of various cancers, optionally in combination with various agents.
    Type: Grant
    Filed: April 6, 2015
    Date of Patent: October 8, 2019
    Assignee: Incuron, Inc.
    Inventor: Catherine Burkhart
  • Use of facilitates chromatin transcription complex (FACT) in cancer
    Patent number: 10386370
    Abstract: The present invention relates to, inter alia, measuring of at least one component of the facilitates chromatin transcription complex (FACT) for evaluating a tumor, including, for example, determining the aggressiveness of a tumor and directing treatment.
    Type: Grant
    Filed: February 11, 2014
    Date of Patent: August 20, 2019
    Assignee: Incuron, Inc.
    Inventor: Katerina Gurova
  • Carbazole compounds and therapeutic uses of the compounds
    Patent number: 10137109
    Abstract: Compounds of the general structural formula (I) and (II) and use of the compounds and salts and hydrates thereof, as therapeutic agents are disclosed. Treatable diseases and conditions include cancers, inflammatory diseases and conditions, and immunodeficiency diseases. (I), (II).
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: November 27, 2018
    Assignee: INCURON, INC.
    Inventors: John Tucker, Sergey Sviridov, Leonid Brodsky, Catherine Burkhart, Andrei Purmal, Katerina Gurova, Andrei Gudkov